RATIONALE: Systemic and local eosinophilia is thought to contribute to disease progression in acute and chronic lesions of patients with atopic dermatitis. We have previously shown an increase in eosinophil lineagecommitted progenitors (EoP) in skin during the late cutaneous response after intradermal allergen challenge, and in chronic skin lesions from patients with atopic dermatitis. This study examined the relationship between levels of EoP in the skin, and atopic dermatitis clinical scores, EASI and SCORAD. METHODS: Sixteen patients with moderate-to-severe atopic dermatis underwent full skin assessments using EASI and SCORAD scores. After 8 days of systemic steroid washout, intradermal challenge was performed with allergen and saline control. 24 hours later, biopsies were obtained from the site of the late cutaneous response and from a chronic lesion. Immunofluorescence staining was performed on skin biopsies. EoP defined as CD34+ve/IL-5Ra+ve/Von Willebrand factor-ve were measured in the papillary dermis using Nikon Imaging Software Analysis. Levels of EoP were compared to EASI and SCORAD using non-parametric Spearman correlation. Boston Children's Hospital, Boston, MA. RATIONALE: Staphylococcus aureus (S. aureus) commonly colonizes the skin of patients with atopic dermatitis (AD) and its presence correlates with disease severity. The factors that promote colonization of AD skin with S. aureus are not fully understood. We investigated the potential reciprocal relationship between S. aureus skin infection and allergic skin inflammation.
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-/-mice and WT controls were epicutaneously (EC) sensitized with ovalbumin (OVA) or saline as control, and superficially infected with S. aureus. Cytokine mRNA expression was assessed by quantitative PCR, cell infiltrates were evaluated by flow cytometry, and bacterial burden was evaluated by counting colony-forming units in skin homogenates. RESULTS: OVA sensitized mouse skin exhibited increased S. aureus loads compared to saline sensitized skin. Superficial S. aureus application on OVA sensitized skin sites exaggerated infiltration by CD45 + cells, CD4 + T cells, eosinophils, basophils, ILCs and neutrophils. In addition, it enhanced Il4 and Il13 expression and decreased Il17a expression, but had no detectable effect on Ifng mRNA expression. Bacterial loads following S. aureus application to OVA sensitized skin were lower in Il4 -/-,Il13 -/-and Il4/Il13 -/-mice compared to WT controls. CONCLUSIONS: Our results suggest a feed forward loop in which cutaneous S. aureus infection aggravates allergic skin inflammation and enhances the local type 2 responses, which in turn promote S. aureus growth and/or persistence. RATIONALE: NSAIDs are among the most used drugs worldwide and also induce a number of hypersensitivity reactions, mainly without the participation of specific immunological recognition mechanisms. It is believed that the inhibition cyclooxygenase-1 directs the arachidonic acid pathway towards the release of cysteinyl-leukotrienes (CysLTs), triggering a reaction in some individuals. The most common clinical phenotype is aspirin (or NSAIDs)-induced acute urticaria/angioedema (AIUA). Two key enzymes are involved in CysLTs biosynthesis: arachidonate 5-lipoxygenase (ALOX5) and leukotriene C4 synthase (LTC4S). Considering that individual susceptibility to develop AIUA may be under the influence of genetic factors, we analyzed the potential involvement of genetic variants in these enzymes in this pathology. METHODS: A total of 569 individual were included: 269 AIUA patients and 300 healthy controls, without significant sex or age differences between them. We selected 19 tag single nucleotide polymorphisms (tSNPs) in ALOX5 and 2 in LTC4S according to the 1000 Genomes Project data for Europeans, which were genotyped using the iPlex Sequenom Mass Array technology. RESULTS: The ALOX5 rs28395868 intronic variant was linked to an increased risk of AIUA (OR52.61, IC51.37-4.98), remaining this association statistically significant after Bonferroni multiple testing correction (corrected p-value50.015). A marginal association for the ALOX5 intronic tSNP rs3780901 was also found. CONCLUSIONS: Our results suggest a role for ALOX5 genetic variants in AIUA, potentially by affecting splicing mechanisms. However, additional studies are necessary to replicate our findings and to disentangle these associations at molecular level.
